The PennZone

  • Home
  • Non-profit
  • Books
  • Health
  • Marketing
  • Sports
  • Business
  • Music
  • Entertainment

Ponos Industries LLC Amends Previously Announced Tender Offer for up to 14,000,000 Shares of Common Stock of AT&T Inc
The PennZone/10039731

Trending...
  • Ryan J. Murphy Named as 2026 Irish Legal 100 Honoree
  • Tek84 Unveils New Brand Identity Built to Magnify What Security Officers Can Do
  • Gahl Sasson Releases "Agents of Chaos & Angels of Change: The Astrology of 2027
NEW YORK - PennZone -- Ponos Industries LLC ("Purchaser") announces an amendment to its previously-announced tender offer (the "Offer") to acquire up to 14,000,000 shares of common stock (the "Shares") of AT&T Inc. for $36.00 per Share (the "Offer Price"), less dividends since September 10, 2018, such that the Offer will expire at 5:00 p.m., New York City time, on Monday, October 21, 2019, unless extended or earlier terminated (the "Expiration Date"). The Offer was previously scheduled to expire at 5:00 p.m., New York City time, on Friday, November 8, 2019. All other terms and conditions of the Offer remain unchanged.

As of 5:00 p.m., New York City time, on Friday, October 11, 2019, approximately 1,400,000 Shares had been tendered and not withdrawn from the Offer.

The Offer is subject to closing conditions set forth in the Offer to Purchase, dated September 10, 2018, including the closing price of the Shares on the NYSE on the last full trading day prior to the Expiration Date exceeding the Offer Price and Purchaser obtaining financing necessary to fund Purchaser's financial obligations arising from the Offer.

This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell shares or any other securities. The Offer to Purchase common stock of AT&T Inc. is only being made pursuant to the Offer to Purchase and Letter of Transmittal with respect to the Offer, as such documents may be supplemented and amended from time to time. Shareholders are urged to read these materials carefully because they contain important information, included the terms and conditions of the Offer, that shareholders should consider before making any decision regarding tendering their Shares. Shareholders can obtain a copy of the Offer to Purchase and Letter of Transmittal with respect to the Offer by contacting the information agent at (888) 422-4311 OR INFOAGENT@ponoscapital.com. Copies of materials and any documentation must not be mailed, distributed or sent in, into or from any jurisdiction where to do so would be unlawful.

More on The PennZone
  • Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth
  • Charlie Shaw and Patrick Carragher win SEO Agency of the Year 2026
  • Canadian Woman Plants 1,667 Love Stories in a Field of Peonies That Could Bloom for 100 Years
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Beyond the Odds: BetQL Combines Sharp Money Trends and Real Time Odds to Help Bettors Find Value

Ponos Industries LLC is a private investment company that invests in publicly traded securities whose value it expects to appreciate over a 12-month period.

Forward Looking Statements

Statements included in this press release that are not historical facts are forward-looking statements, which involve a number of risks and uncertainties and are subject to change at any time. While Purchaser may elect to update forward-looking statements in the future, Purchaser specifically disclaims any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

Source: Ponos Capital

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Extreme Lead Program Highlights $27 Real Human Traffic Test for Affiliate and Network Marketers
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
  • Datavalet Named One of Quebec's Best Workplaces™ for 2026
  • Phinge Corporation Engages Sheridan Ross PC for Certain Intellectual Property Matters
  • Alan Hamilton of Shiver Hamilton Campbell Inducted as a Fellow of the American College of Trial Lawyers
  • Slotozilla Hosts Exclusive Halloween Casino Bonuses for 2026
  • One Night. One Encounter. A New Season Of Purpose
  • "BROOKLYN, BROOKLYN, BROOKLYN" children's book and official YouTube channel launch on October 27th
  • Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
  • Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network
  • Dynamic Relaunch as AI Predictive Cybersecurity Company Optimized to Prevent Threats Proactively: Cycurion, Inc. (N A S D A Q: CYCU)
  • EMBER™ Unveils the Workplace Identity Score™ (WIS™), the First Standard for Measuring Workplace Impact on Workforce Performance & Business Growth
  • With Oil Prices Surging…Sky Quarry's Nevada Refinery Is Back in Action — CEO Highlights a Powerful New Growth Chapter for (N A S D A Q: SKYQ)
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
  • We are Talker Study: 64% of AI Users Have Bought From a Brand AI Introduced, as The Invisible Shortlist Reshapes Brand Discovery
  • One in three Americans may have lost track of retirement savings from a previous job
  • Political Concerns Drive US Investors to Golden Visas
  • The Truth Makers: The Quantum Lie Turns a Presidential Bribery Video Into a Crisis of Reality
  • 2027 Health Insurance Open Enrollment
  • Ryan J. Murphy Named as 2026 Irish Legal 100 Honoree

Popular on PennZone

  • SMACK Fighting Championships Announces Influencer Fight Night at Harrah's Philadelphia - 163
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026 - 124
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry - 103
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry - 101
  • From Newcomers to Neighbors: LINC Celebrates the People Who Make the Valley Home
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of
  • BJJ App mmaGPT Expands Academy Program to Support Jiu-Jitsu Instructors with AI Technique Coaching
  • New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January

Similar on PennZone

  • Dynamic Relaunch as AI Predictive Cybersecurity Company Optimized to Prevent Threats Proactively: Cycurion, Inc. (N A S D A Q: CYCU)
  • With Oil Prices Surging…Sky Quarry's Nevada Refinery Is Back in Action — CEO Highlights a Powerful New Growth Chapter for (N A S D A Q: SKYQ)
  • BESTBUYSTORE opens its dropshipping model to independent merchants
  • Navigating a Changing Market: How AIX Group Is Responding to a Challenging Year
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST)
  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us